Belite Bio (BLTE) earnings, May 20, 2026: EPS +24%, stock +2.6%
In brief
Belite Bio reported on May 20, 2026. Earnings per share changed +24% year over year, 46.4% above the estimate; revenue 0%. The stock opened with a +1.7% gap and closed the day +2.6% (May 20, 2026). The stock is now 28.4% below its 52-week high, +27.4% over 12 months. Next report: Nov 17, 2026.
EPS vs estimate+46.4%
EPS, YoY+24%
Revenue, YoY0%
Gap · day+1.7% · +2.6%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 20, 2026 | +1.7% | +2.6% |
Next-quarter estimates, ratings and the BLTE chart are in the terminal.
Open the terminalFAQ
When is Belite Bio's next earnings report?
Nov 17, 2026. The date comes from daily data and is corrected if the company moves it.
How did Belite Bio stock react to the report?
Opening gap +1.7%, day's result +2.6%.
Did Belite Bio's earnings grow?
Earnings per share rose 24% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.